Interstitial Cystitis & Bladder Pain Protocol
Interstitial Cystitis & Bladder Pain Protocol framework focused on consistent execution, practical monitoring, and safer progression.
A targeted protocol for interstitial cystitis (IC) and bladder pain syndrome combining peptides with anti-inflammatory, bladder mucosal healing, smooth muscle relaxation, and central pain modulation properties.
Who it's for
Use this as an educational framework with clinical oversight. Keep timing consistent, track response daily, and change one variable at a time after trend review. Pair protocol use with sleep, nutrition, and recovery fundamentals.
Free Peptide Guide
Interstitial Cystitis & Bladder Pain Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Protocol at a Glance
Cycle Duration
12 weeks initial course, then maintenance dosing as needed
Target Audience
Individuals diagnosed with interstitial cystitis, bladder pain syndrome, or painful bladder syndrome under urologist care
| Compound | Dose | Frequency |
|---|---|---|
| BPC-157 Urothelial healing and neurogenic inflammation reduction | 250 mcg | Twice daily |
| VIP Bladder smooth muscle relaxation and mast cell inhibition | 50 mcg | Twice daily (intranasal or SC) |
| KPV Mast cell and macrophage-driven bladder inflammation suppression | 500 mcg | Daily |
| TB-500 Urothelial repair and anti-fibrotic bladder wall healing | 5 mg | Twice weekly |
| NAD+ Pelvic floor tissue mitochondrial health support | 500 mg | Daily |
Free Peptide Guide
Interstitial Cystitis & Bladder Pain Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Daily Schedule
Morning
Baseline review and first execution window
Log sleep, energy, and tolerance; complete planned BPC-157 timing if scheduled.
Midday
Adherence and symptom check
Review hydration, workload, and side effects before any changes.
Evening
Recovery closeout and next-day setup
Record outcomes, maintain schedule consistency, and prepare next-day protocol.
Safety
- Escalating side effects or new concerning symptoms require prompt clinical review.
- Avoid abrupt multi-compound changes during unstable periods.
- Maintain regular follow-up with a licensed clinician throughout the cycle.
Not appropriate for unsupervised use or as a replacement for diagnosis and medical care. Use only within a clinician-guided plan.
Who should avoid
- Anyone using this protocol without qualified medical supervision
- People with unstable medical or psychiatric conditions without specialist guidance
- Pregnant or breastfeeding individuals unless explicitly cleared by a physician
Common Mistakes
Changing multiple variables at once
Why it matters: This makes it hard to identify what improved outcomes versus what increased side effects.
How to fix: Keep one-variable changes per review cycle and log response for several days.
Ignoring adherence and recovery fundamentals
Why it matters: Protocol effectiveness drops when sleep, nutrition, and routine consistency are unstable.
How to fix: Protect daily anchors first, then optimize protocol details gradually.
FAQ
How long should Interstitial Cystitis & Bladder Pain Protocol run before reassessment?
A common window is 12 weeks initial course, then maintenance dosing as needed, with periodic review of tolerance and objective trends.
Can I increase complexity quickly for faster results?
Usually no. Safer optimization comes from staged changes and clear tracking.
What should I track each day?
Track schedule adherence, symptoms, sleep quality, and any adverse effects in one log.
Key Takeaways
- Consistency with BPC-157 + VIP execution matters more than frequent protocol changes.
- Single-variable adjustments improve safety and decision quality.
- Objective daily tracking supports better long-term outcomes.
Why This Stack Works
BPC-157 promotes healing of the damaged urothelial lining and reduces the neurogenic inflammation driving IC pain. VIP is a potent inhibitor of bladder smooth muscle contractions and mast cell degranulation in the bladder wall, with anti-inflammatory effects directly relevant to IC pathophysiology. KPV suppresses the mast cell-mediated and macrophage-driven inflammation that perpetuates bladder wall damage. TB-500 accelerates urothelial repair and reduces fibrosis. NAD+ supports the mitochondrial health of chronically inflamed pelvic floor tissues.
Clinical Research
No clinical references were provided for this stack yet.
More Recovery & Repair Stacks
ALS & Motor Neuron Disease Supportive Care
A neuroprotective peptide protocol for ALS and motor neuron disease, targeting mitochondrial function, neuroinflammation, and remaining motor neuron survival without interfering with standard-of-care riluzole therapy.
Acute Injury & Emergency Recovery Protocol
Rapid-response peptide protocol for acute injuries, post-surgical recovery, or critical illness support. Designed to initiate within 24–48 hours of injury or procedure.
Advanced Gut Restoration Protocol
The most comprehensive gut healing protocol, targeting intestinal permeability, mucosal growth, epithelial repair, and microbiome defense simultaneously. Suitable for celiac disease, post-antibiotic dysbiosis, IBD, short bowel syndrome, and chronic leaky gut.
Medical disclaimer: This protocol is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.
Free Peptide Guide
Interstitial Cystitis & Bladder Pain Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.